AACR (American Association for Cancer Research) can be accessed at aacr.org . The conference doesn't begin until the end of the month: I recognize two Ligand presentors (in bold) and many areas of interest (in itallics) highlighting is not complete
DAILY CALENDAR OF EVENTS
(All events in Morial Convention Center except those marked "Hilton" which are in the New Orleans Hilton
Riverside -- Names of session chairpersons are underlined)
SATURDAY, MARCH 28, 1998
8:00 a.m.-1:30 p.m. Associate Member Grant-Writing Session - Hilton Salon A
9:30 a.m.-12:00 noon Public Forum - Ballroom A
12:00 noon-2:00 p.m. Educational Sessions
ED1 Molecular Epidemiology: Current Perspectives - Neil E. Caporaso, Rashmi Sinha, Lea C. Harty, Christine B.
Ambrosone, Nathaniel Rothman - Room 41
ED2 Cell Cycle Regulation - Andrew Koff, Michele Pagano, Ronald A. DePinho, Neal Rosen - Room 43
2:00 p.m.-6:15 p.m. Methods Workshops
WK1 Bioinformatics in Cancer Research - Andy Baxevanis, Francis Ouellette, David Landsman, Gregory W. Schuler,
James Fickett, Daniel W. Zaharevitz - Room 6
WK2 Establishment, Maintenance, and Quality Control of Biorepositories - Elio Riboli, Elaine Gunter, Susan Hankinson,
H. Bas Bueno de Mesquita, Paola C. Muti, David E. Shuker, David I. Thurnham - Room 9
2:15 p.m.-4:15 p.m. Educational Sessions
ED3 Cancer Research and the FDA - Robert J. DeLap, Patricia Keegan, Janice P. Dutcher, Patricia Delaney - Ballroom A
ED4 Signaling for Apoptosis - Douglas R. Green, John A. Hickman, Richard N. Kolesnick - Ballroom C
4:30 p.m.-6:30 p.m. Educational Sessions
ED5 Steroid Receptors, Orphan Receptors, and Significance of Population Variation - Candace S. Johnson, V. Craig
Jordan, J. Wesley Pike, Vincent GiguŠre, Gerhard A. Coetzee - Ballroom A
ED6 Basic Biology of Tyrosine Kinases - Gregory D. Plowman, Ben Margolis, Mark Henkemeyer - Ballroom C
6:15 p.m.-8:00 p.m. MEG/AACR Business Meeting and Reception - Room 24
6:30p.m.-8:30 p.m. WICR Reception and Speaker - Hilton Napoleon Room
8:00 p.m.-10:00 p.m. Opening Mixer - Hilton Salon A-C
SUNDAY, MARCH 29, 1998
6:45 a.m.-7:45 a.m. State Legislative Committees Breakfast - Hilton Salon A
7:00 a.m.-8:00 a.m. NIH Grants Session - Room 38
7:00 a.m.-8:00 a.m. Sunrise Sessions
Cancer Genome Anatomy Project (CGAP): Update and Potential, Paul S. Meltzer - Room 26
JAKs, STATs and Src Kinases: Obligate Partners in Cytokine Signaling, E. Premkumar Reddy - Room 36
Histone Acetylation and Transcriptional Regulation, Tony Kouzarides - Room 6
Molecular Genetics of Brain Tumors, Sandra H. Bigner - Room 11
Genetic Analysis of Tumor Suppression by COX-2 Inhibitors, Makoto M. Taketo - Room 9
Sequence-specific Gene Regulation: Applications of Ribozymes in Preclinical Models of Cancer, Thale C. Jarvis - Room
25
Gene Transfer to Hematopoietic Progenitors, Fulvio Mavilio - Room 24
Genetic Testing for Breast Cancer Susceptibility: Psychosocial and Clinical Research Update, Caryn E. Lerman - Room
1
Nuclear Hormone Receptors in Development and Disease, Vincent GiguŠre - Room 3
Opening Event
8:00 a.m.-9:00 a.m. Presidential Address
Cancer Cell Structure: Aberrations in the Decoder of DNA, Donald S. Coffey - Exhibit Hall C
9:00 a.m.-12:00 noon Plenary Session
New Horizons in Cancer Research, Frank J. Rauscher, III, Erkki Ruoslahti, Drew Pardoll, Bert Vogelstein, Waun Ki Hong,
Richard D. Klausner, Donald S. Coffey, Exhibit Hall C
12:00 noon-12:15 p.m. Elion Award Presentation - Exhibit Hall C
8:00 a.m.-12:00 noon Poster Sessions
RR1 Radiobiology/Radiation Oncology I - Section 1
IM1 Vaccines and Immunotherapy - Section 2
EN1 Breast Cancer and Prostate Cancer - Section 3
PR1 Diet and Cancer Prevention - Section 4
CG1 Premalignant Changes and p53 Metabolism - Section 5
MB1 p53 Tumor Suppressor Function - Section 6
MB2 Tumor Suppressors Involved in Breast, Renal and Endocrine Neoplasia - Section 7
MB3 Oncogenes and Signal Transductions - Section 8
BL1 Angiogenesis and Tumor Physiology I - Section 9
BL2 Angiogenesis and Tumor Physiology II - Section 10
CL1 Tumor Staging: Correlation of Clinical and Molecular Markers I - Section 11
CL2 Prostate/Breast/Brain - Section 12
PT1 Cancer Gene Therapy I - Section 13
PT2 Therapeutic Agents and Receptors - Section 14
PT3 Mechanisms of Action of New Anticancer Agents - Section 15
PT4 P-Glycoprotein-mediated Drug Resistance - Section 16
12:00 noon-5:00 p.m. Exhibit Show - Exhibit Hall A-B
12:15 p.m.-1:15 p.m. - G. H. A. Clowes Memorial Award Lecture - The Regulation and Function of the p53 Tumor
Suppressor Protein - Arnold J. Levine - Exhibit Hall C
1:15 p.m.-2:15 p.m. Associate Member Business Meeting - Room 11
1:15 p.m.-5:15 p.m. Poster Discussion Sessions
IM2 T-Cells in Cancer Immunology - Room 17
PR2 Translational Research in Cancer Prevention - Room 38
PT6 Molecular Responses to Cytotoxic Agents - Room 14
MB4 DNA Methylation - Room 40
BL4 Anti-Angiogenesis Therapy - Room 6
1:15 p.m.-5:15 p.m. Poster Sessions
EP1 Cancer Epidemiology - Section 1
EN2/PT7 Vitamin D, Retinoids and Differentiation - Section 2
EN3 Growth Factors and Cytokines - Section 3
PR3 Cancer Prevention: Biomarkers - Section 4
CG3 Modulation of Cellular Transformation - Section 5
MB5 Candidate Genes and Models of Carcinogenesis - Section 6
MB6 Candidate Genes and Novel Loci - Section 7
MB7 Viral Carcinogenesis - Section 8
BL5 Apoptosis I: Chemical and Biological Inducers and their Effectors - Section 9
BL6 Apoptosis II: Growth Factor and Hormonal Regulation - Section 10
BL7 Angiogenesis and Tumor Physiology III - Section 11
IM3 Clinical Cytokines - Section 12
PT8 Mechanisms of Antitumor Activity of Platinum Drugs - Section 13
PT9 Platinum Agents - Section 14
PT10 Antitubulin Agents - Section 15
PT11 Mechanisms of Drug Resistance - Section 16
1:30 p.m.-5:00 p.m. Minisymposia
RR2 Molecular Aspects of Radiation Responses - Room 36
CG2 Cooperative Molecular Interactions in Tumor Promotion and Progression - Room 24
PT5 Biochemical Pharmacology of DNA Topoisomerase Poisons - Room 25
BL3 Extracellular Matrix Proteases in Invasion - Room 9
2:15 p.m.-4:45 p.m. Symposia
S1 Telomerase and Telomeres in Normal and Neoplastic Cells Ronald A. DePinho, Jerry W. Shay, Virginia A. Zakian,
Calvin B. Harley, Ballroom A
S2 Inherited Cancer Susceptibility Syndromes: Genetics, Genes and Function, Daniel A. Haber, Yosef Shiloh, Bert
Vogelstein, Sanford Markowitz, Parry J. Guilford, Andrea I. McClatchey, Ballroom C
S3 Cancer Gene Therapy: New Concepts and Clinical Applications, Jack A. Roth, Howard A. Fine, Joanne T. Douglas,
Xandra O. Breakefield, Luigi Naldini, Room 43
S4 The Promise of Oncogene-based Drug Targeting, Alex Matter, Gregory L. Verdine, Calvin B. Harley, Frank
McCormick, Michael Eck, Room 41
5:00 p.m.-6:00 p.m. AACR Pezcoller Award Lecture - SH2 Domains and Modular Control Signal Transduction
Pathways - Anthony J. Pawson - Exhibit Hall C
6:30 p.m.-9:00 p.m. Minority Issues Careers Symposium - Hilton Salon A
9:00 p.m.-11:30 p.m. Annual Reception - Hilton Grand Ballroom
MONDAY, MARCH 30, 1998
7:00 a.m.-8:00 a.m. WICR Mentoring Session - Hilton Salon A
7:00 a.m.-8:00 a.m. Sunrise Sessions
Molecular Pathogenesis of Non-Hodgkin's Lymphoma, Riccardo Dalla-Favera, Room 11
Hormonal Regulation of Cell Growth and Differentiation, Lorraine J. Gudas, Room 26
Alterations of Cell Cycle Controls in Cancer, Giulio F. Draetta, Room 24
Proteases in Cancer: Clinical Significance and Mechanisms in Metastasis, Henri Rochefort, Room 9
Inherited Cancers of the Kidney: Family Studies, Genes, and Biochemistry, W. Marston Linehan, Room 6
Strategies for Combining Chemotherapy and Biotherapy, Antonio C. Buzaid, Room 1
Antimetabolites: New Insights into Cell Death/Signal Transduction Pathways as Determinants of Drug Sensitivity,
Steven Grant, Room 25
Interleukin-12: Biological and Clinical Developments, Giorgio Trinchieri, Room 36
Chemoprevention Trials: Progress and Promise, Scott M. Lippman, Room 3
8:00 a.m.-10:30 a.m. Symposia
S5 Tumor Angiogenesis and Microcirculation: An Integrated Approach, Rakesh K. Jain, George D. Yancopoulos, Robert
S. Kerbel, Isaiah J. Fidler, James M. Pluda, Ballroom A
S6 Signaling by wnt-1, á-Catenin, and the APC Tumor Suppressor in Cancer, Paul Polakis, Kenneth W. Kinzler, Walter
Birchmeier, Randall T. Moon, Ballroom C
S7 Prostate Cancer: Basic Science and Clinical Aspects, Leland W.K. Chung, Peter T. Scardino, Howard I. Scher, John
T. Isaacs, Timothy J. McDonnell, Room 41
S8 Molecular Determinants of Cellular and Tumor Responses to Radiation, Michael B. Kastan, Michael Karin, Amato J.
Giaccia, Theodore S. Lawrence, Room 43
8:00 a.m.-12:00 noon Poster Discussion Sessions
EP2 High and Low Penetrance Genes in Molecular and Genetic Epidemiology, Room 14
CG4 Molecular Basis of Mutagenesis, Room 17
CL3 Experimental and Clinical Pharmacology - Antimetabolites, Room 38
PT14 Antitubulin Agents, Room 40
8:00 a.m.-12:00 noon Poster Sessions
PR4 Cancer Prevention: New Agents I - Section 1
BL9 Markers of Cell Differentiation - Section 2
BL10 Control of Cell Growth and Differentiation by Kinase Receptors - Section 3
BL11 Expression of Invasion-related Genes - Section 4
PT15 Modulation of Drug Resistance - Section 5
PT16 DNA Damaging Agents - Section 6
PT17 Novel Agents - Section 7
CL4 Diagnosis/Prognosis Markers I - Section 9
CL5 Diagnosis/Prognosis Markers II - Section 10
CG5 DNA Repair and Mutagenesis - Section 11
MB9 Cell Cycle Checkpoints - Section 12
MB10 Promotor/Enhancer Analysis - Section 13
MB11 G1/S Cell Cycle Transition - Section 14
MB12 Epigenetics and Gene Expression - II - Section 15
IM5 Tumor Antigens - Section 16
8:15 a.m.-11:45 a.m. Minisymposia
IM4 Dendritic Cells in Immunotherapy, Room 36
BL8 Apoptosis III: Indictment, Judgment, Execution and Reprieve, Room 6
PT12 Novel Agents and Targets, Room 24
PT13 Downstream Effects of Cytotoxic Drugs and Reversal of Checkpoint Abrogation, Room 25
MB8 Transcriptional Regulation of Cell Transformation and Tumor Progression, Room 9
10:00 a.m.-4:00 p.m. Exhibit Show - Exhibit Hall A-B
10:45 a.m.-12:00 noon Controversy Session
CON1: Environmental Estrogens and Cancer, Nancy E. Davidson, Mary S. Wolff, Steven Safe - Ballroom A
12:00 noon-1:00 p.m. Joseph H. Burchenal/AACR Clinical Research Award Lecture: The Biology and Therapy of
Breast Cancer: Reflections from Several Perspectives - Bernard Fisher - Exhibit Hall C
1:00 p.m.-2:15 p.m. Session on Survivors and Cancer Research - Ballroom A
1:00 p.m.-5:00 p.m. Poster Discussion Sessions
EN4 Vitamin D, Retinoids and PPARS - Room 14
PT19 Prodrug and Drug Delivery - Room 17
RR3 Radiobiology/Radiation Oncology - Room 40
MB14 Role of Tumor Suppressors in Human Cancer Development - Room 38
EP3 Biomonitoring Methods for Detection of Carcinogen-DNA Adducts in Human Populations - Exhibit Hall A-B, Section
1, with discussion in Room 11
1:00 p.m.-5:00 p.m. Poster Sessions
PR6 Cancer Prevention: New Agents II - Section 2
BL13 Proteases, Expression and Regulation - Section 3
BL14 Protease Inhibition in Invasion and Metastasis- Section 4
PT20 Novel Drugs/Targets - Section 5
PT21 Novel Combination Therapy - Section 6
PT22 Modulators of Growth and Differentiation - Section 7
PT23 Signal Transduction Inhibitors - Section 8
CL7 Phase I Clinical Trials - Section 9
CL8 Clinical Pharmacology - Section 10
CG6 Environmental Carcinogenesis - Section 11
CG7 Biomarkers and Environmental Exposure - Section 12
MB15 Allelic Loss And Cancer - Section 13
MB16 Comparative Genomic Hybridization and Differential Gene Expression - Section 14
MB17 Epigenetics and Gene Expression II - Section 15
IM6 Clinical Cellular-Based Immunotherapy - Section 16
1:30 p.m.-5:00 p.m. Minisymposia
PR5 New Agents for Cancer Prevention, Room 36
CL6 Breast Cancer, Room 9
PT18 Farnesyltransferase Inhibitors, Room 6
BL12 Positive and Negative Regulators of Angiogenesis, Room 24
MB13 Viral and Cellular Oncogenes, Room 25
2:30 p.m.-5:00 p.m. Symposia
S9 The bcl-2 Family: Death Agonists and Antagonists, Stanley J. Korsmeyer, Jerry M. Adams, Craig B. Thompson,
Yoshihide Tsujimoto, Eileen P. White, Ballroom A
S10 The Molecular Basis of Immune Recognition: Basic Concepts with Therapeutic Implications, Giorgio Trinchieri,
Jacques F. Banchereau, Antonio Lanzavecchia, Hans Schreiber, Hyam I. Levitsky, Room 41
S11 Genetic Approaches to Diagnosis: The Impact of Molecular Medicine on Early Detection and Diagnosis, David
Sidransky, M. Michele Manos, Philippe G. Anker, Klaus Pantel, Room 43
S12 New Concepts in Chemotherapeutics and Drug Resistance, Susan Band Horwitz, John S. Lazo, D. Lansing Taylor,
Inder M. Verma, I. David Goldman, Ballroom C
5:15 p.m.-6:15 p.m. NCI Board of Scientific Advisors Session - Ballroom A
6:15 p.m.-7:15 p.m. Business Meeting of Members - Ballroom A
7:30 p.m.-9:30 p.m. WICR 10th Anniversary Symposium - Hilton Salon A
7:30 p.m.-9:00 p.m. NCI Training Branch Session - Hilton Salon B
TUESDAY, MARCH 31, 1998
7:00 a.m.-8:00 a.m. Associate Member Sunrise Session - Hilton Salon A
7:00 a.m.-8:00 a.m. Sunrise Sessions
Integrin Signaling and Cell Growth Control: Consensus and Controversies, Rudolph L. Juliano - Room 24
Growth Factor Signaling: The IGF-1, IGF-2 System in Cancer, Haim Werner - Room 25
Pathogenesis of Acute Promyelocytic Leukemia, Pier Giuseppe Pellici - Room 36
Radiation Sensitization: Basic and Clinical Aspects, Rupert K. Schmidt-Ullrich - Room 1
Advances in Mechanisms of Drug Resistance: Basic Science and Clinical Implications, Susan E. Bates - Room 6
Familial Cancer Syndromes: Genetic Tests and Clinical Approaches, Ken Yamaguchi - Room 26
Harnessing the Immune System in Tumor Therapy: Manipulating Stimulatory and Inhibitory Signals in T-Cell
Activation, James P. Allison - Room 11
Issues and Applications in Molecular Epidemiology, Barbara S. Hulka - Room 3
New Therapeutic Developments with Polyamine-directed Analogs and Inhibitors, Carl W. Porter - Room 9
8:00 a.m.-10:30 a.m. Symposia
S13 Cell Death Signaling Pathways: Caspase Cascades and Effectors/Initiators of Apoptosis, Douglas R. Green, Vishva
M. Dixit, John C. Reed, Xiaodong Wang, Richard A. Flavell, Ballroom A
S14 p53/p73: An Emerging Gene Family, William G. Kaelin, Daniel Caput, Frank McKeon, Ute Moll, Motonobu Osada,
Ballroom C
S15 Breast Cancer: Basic Science and Clinical Aspects, Sofia D. Merajver, Stephen Paul Ethier, Paul S. Meltzer, Laura
Esserman, Joseph Ragaz, Room 41
S16 Cancer Biology in Context: Stromal-Epithelial, Cell-Cell, and Cell-Extracellular Matrix Interactions in Normal
Development and Cancer, Mina J. Bissell, Keld Dano, Lynn M. Matrisian, Gopalan Shyamala, Raymond L. White, Room
43
8:00 a.m.-12:00 noon Poster Discussion Sessions
IM7 Vaccines for Immunotherapy - Room 38
CG8 Cellular Response to Oxidative Stress - Room 14
PT26 DNA Topoisomerase Poison Action and Resistance - Room 40
BL15 Host-Tumor Interactions: Angiogenesis and Metastasis - Room 17
8:00 a.m.-12:00 noon Poster Sessions
RR4 Radiobiology/Radiation Oncology II - Section 1
EN5 Steroid Hormone Metabolism and Hormonal Carcinogenesis
PR8 Cancer Prevention: New Agents III - Section 3
CG9 Metabolism and Genetic Susceptibility - Section 4
BL16 Downstream Signaling Events - Section 5
BL17 Growth Factors - Section 6
BL18 Signaling Through Transcription Factors - Section 7
CL10 Tumor Staging: Correlation of Clinical and Molecular Markers II - Section 8
PT27 Adenovirus and Antisense Therapeutics - Section 9
PT28 Compounds Targeted on DNA Topoisomerase, Their Action and DNA Topoisomerase - Section 10
PT29 Drug/Drug Delivery - Section 11
PT30 Antimetabolites and TMP Synthetase - Section 12
IM8 Clinical Antibody-based Immunotherapy - Section 13
MB18 Deregulation of Cell Cycle Controls in Cancer - Section 14
MB19 Transcriptional Control of Cell Differentiation - Section 15
MB20 Transcriptional Control and Chromatin Structure - Section 16
8:15 a.m.-11:45 a.m. Minisymposia
PR7 Novel Retinoids in Cancer Chemoprevention - Room 24
CL9 Human Cancer Gene Therapy - Room 25
PT24 P-Glycoprotein: Function and Modulation - Room 6
PT25 Pharmacogenetic- and Pharmacogenetic-guided Studies of New Agents - Room 9
EP4 Molecular Basis of Cancer Susceptibility - Room 36
10:00 a.m.-4:00 p.m. Exhibit Show - Exhibit Hall A-B
10:30 a.m.-12:00 noon Late-Breaking Research Session - Exhibit Hall C
12:15 p.m.-1:15 p.m. Richard and Hinda Rosenthal Foundation Award Lecture: From the Human B-Cell Surface
to the Bedside, Lee M. Nadler - Exhibit Hall C
1:00 p.m.-5:00 p.m. Poster Discussion Sessions
BL20 Cell Growth and Apoptosis I: Fas, bcl2, and Downstream Events - Room 38
CL11 Molecular Markers for Cancer Susceptibility - Room 14
PT32 Mechanism and Determinants of Antimetabolites - Room 17
MB23 Novel Genes and Loci - Room 40
1:00 p.m.-5:00 p.m. Poster Sessions
EP5 Genetic Epidemiology - Section 1
EN6 Estrogen Receptors, Corticosteroids and Other Hormones - Section 2
CG11 Aberrant Gene Expression in Tumor Promotion and Progression - Section 3
CG12 Gene Expression and Genotoxicity - Section 4
BL21 Regulation of Invasion-related Genes - Section 5
BL22 Adhesion in Invasion and Metastasis: Receptors and Signaling Events - Section 6
CL12 Phase II Clinical Trials - Section 7
CL13 Modality-based Clinical Research - Section 8
PT33 Cancer Gene Therapy II - Section 9
PT34 Cancer Gene Therapy III - Section 10
PT35 Pharmacokinetics, Drug Metabolism, and Distribution - Section 11
PT36 Topoisomerase I and II Poison-based Drug Combination - Section 12
IM9 Immunomodulation - Section 13
MB24 Replication Error Phenotype - Section 14
MB25 Epigenetics and Gene Expression III - Section 15
MB26 Role of p53 and Cell Cycle Genes in Cancer - Section 16
1:30 p.m.-2:30 p.m. Cornelius P. Rhoads Memorial Award Lecture: Cancer As a Complex Developmental
Disorder, Michael C. Dean - Exhibit Hall C
1:30 p.m.-5:00 p.m. Minisymposia
MB21 Screening of Gene Expression - Room 24
CG10 Genetics of Cancer and Exposure Susceptibility - Room 36
PT31 MDR Gene Regulation - Room 9
BL19 Signaling Through MAP Kinases - Room 6
MB22 Mismatch Repair and Genome Stability - Room 25
2:45 p.m.-5:15 p.m. Symposia
S17 Molecular Targets and Endpoints for Chemoprevention, Waun Ki Hong, John D. Minna, Reuben Lotan, David S.
Alberts, Gary J. Kelloff - Ballroom C
S18 Gastrointestinal Cancer: Basic Science and Clinical Aspects, Kenneth W. Kinzler, Michael Goggins, Brian J. Reid,
William F. Dove, Francis M. Giardiello - Ballroom A
S19 Tumor Virology: Molecular Biology and Etiology, Karl Mnger, Nancy Raab-Traub, Yuan Chang, Kuan-Teh Jeang -
Room 41
S20 Advances in Cancer Vaccine Development, Dorothee Herlyn, Olivera J. Finn, Ralph A. Reisfeld, Soldano Ferrone,
Glenn Dranoff - Room 43
5:30 p.m.-6:30 p.m. Bruce F. Cain Memorial Award Lecture: Translational Research: Walking the Bridge between
Idea and Cure - Bruce A. Chabner - Exhibit Hall C
9:00 p.m.-11:00 p.m. Reception for Methods Workshop Alumni - Hilton Versailles Ballroom
WEDNESDAY, APRIL 1, 1998
7:00 a.m.-8:00 a.m. Sunrise Sessions
Relevance of DNA Damage and Repair for Initiation and Progression of Carcinogenesis: Recent Advances, Jan H.J.
Hoeijmakers, Room 6
Chromosomal Translocations: Genetics, Biology, and Protein Function, James R. Downing, Room 9
Advances in the Mechanisms of Invasion and Metastasis, Isaiah J. Fidler, Room 25
From Slave to Master: The Biological Events During Melanoma Development and Progression, Meenhard Herlyn,
Room 3
Farnesyltransferase Inhibitors: From Bench to Bedside, Ivan D. Horak, Room 36
Topoisomerases: Structure and Function, James C. Wang, Room 24
Progress in Antibody Therapy of Human Cancer, Nancy E. Hynes, Room 26
HIV and AIDS: Factors Involved in Resistance to Infection and Disease Progression, Jay A. Levy, Room 11
Animal Models for Chemoprevention, Michael N. Gould, Room 1
7:30 a.m.-11:30 a.m. Poster Discussion Sessions
PT38 Kinase Inhibitors - Room 14
CG13 p53 Mutation and Expression in Response to DNA Damage - Room 38
BL23 Models and Methods for Invasion and Metastasis - Room 17
MB28 Telomerase - Room 40
8:00 a.m.-9:00 a.m. American Cancer Society Award Lecture: The Past, Present, and Future of the Prevention of
Lung Cancer - Ernst L. Wynder - Ballroom A
8:00 a.m.-10:30 a.m. Symposia
S21 Combinatorial Approaches to the Detection, Treatment, and Understanding of Neoplastic Processes, Jack D.
Keene, Ira Pastan, Kit S. Lam, Lawrence A. Loeb, Lewis T. Williams, H. Mario Geysen - Room 41
S22 New Mechanisms of Action of Viral and Cellular Oncogenes, Elizabeth Moran, Manuel Perucho, Pier Paolo Pandolfi,
Richard Jove, James N. Ihle - Room 43
S23 Reconstruction of Human Tumorigenesis and Progression: Cancer Genetics in Model Organisms, Anthony
Wynshaw-Boris, William F. Dove, Harold Varmus, Pu Paul Liu, Ballroom C
8:00 a.m.-12:00 noon Poster Sessions
BL24 Apoptosis IV - Section 1
BL25 Apoptosis V - Section 2
BL26 Apoptosis V - Section 3
CL15 Experimental Therapeutics - Section 4
CL16 Digestive Tract/Airway/Other - Section 5
PT39 Pharmacology and Preclinical Toxicology - Section 6
PT40 Biological Thereapeutic Agents and Approaches - Section 7
PT41 Antimetabolites - Section 8
IM11 Immunological Approaches to Cancer Therapy - Section 9
MB29 Tumor Suppressors Involved in Signaling - Section 10
MB30 Novel Tumor Suppressor Genes - Section 11
EP6 Molecular Epidemiology - Section 12
CG14 Chemical Carcinogenesis - Section 13
CG15 Tamoxifen and Chemical Carcinogens - Section 14
PR9 Discovery and Assessment of Cancer Chemoprevention Agents - Section 15
8:15 a.m.-11:45 a.m. Minisymposia
IM10 Tumor Immunobiology - Room 24
EN7 Steroid Hormones: Metabolism and Receptors - Room 36
CL14 PSA/PSMA as Targets for Diagnosis, Prognosis and Therapy - Room 25
PT37 Cytoreductive Gene Therapy of Cancer - Room 6
MB27 Function of Tumor Suppressor Genes - Room 9
9:00 a.m.-11:30 a.m. Symposium
S24 Tobacco and Lung Carcinogenesis: Genetics, Biology and Epidemiology, Adi F. Gazdar, William D. Travis, Stephen
S. Hecht, Margaret R. Spitz, Curtis C. Harris - Ballroom A
9:00 a.m.-12:00 noon Exhibit Show - Exhibit Hall A-B
10:45 a.m.-12:00 noon Controversy Session
CON2: Will Multidrug Resistance Modulators Be Effective in the Clinic? Dalia Cohen, William S. Dalton, Antonio T.
Fojo - Ballroom C
12:00 noon - 12:45 p.m. DeWitt Goodman Lecture: Clinical Cancer Prevention Research, Peter Greenwald -
Ballroom A
12:00 noon-4:00 p.m. Poster Discussion Sessions
IM12 Cytokines in Cancer Immunotherapy - Room 14
BL28 Cell Growth and Apoptosis II: Growth Factors and Signaling Pathways - Room 38
PT43 Profiling New Markers in Resistant Cells - Room 17
MB32 Oncogenes and Signaling - Room 40
12:15 p.m.-3:45 p.m. Minisymposia
CL17 Novel Approaches to Organ Site-specific Therapies - Room 24
PT42 Antisense and Biological Therapeutic Approaches - Room 6
CG16 Molecular Mutagenesis - Room 36
BL27 Novel Invasion-related Genes - Room 9
MB31 Novel Mechanisms for Cell Cycle Control - Room 25
12:45 p.m.-3:15 p.m. Symposia
S25 Transcriptional Control of the Neoplastic Phenotype, Frank J. Rauscher, III, Takis S. Papas, Ismail Kola, Michael D.
Cole, Maarten van Lohuizen, William Weiss, Room 43
S26 Restoring Drug Sensitivity to Tumors: New Concepts from Tumor Biology and Physiology, William N. Hait,
Michael M. Gottesman, Carlo M. Croce, Scott W. Lowe, Joseph R. Bertino, Ballroom C
S27 Emerging Issues for Individual Cancer Susceptibility and Risk Assessment, Fred F. Kadlubar, Frederica Perera,
Douglas A. Bell, Neil E. Caporaso, Ballroom A
S28 Epigenetics and Cancer, Stephen B. Baylin and Peter A. Jones, Mitchell S. Turker, Alan P. Wolffe, Melanie Ehrlich,
Room 41 |
